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Abstract A direct hydrogen bond between ubiquinone/quinol
bound at the QO site and a cluster-ligand histidine of the
iron^sulfur protein (ISP) is described as a major determining
factor explaining much experimental data on position of the ISP
ectodomain, electron paramagnetic resonance (EPR) lineshape
and midpoint potential of the iron^sulfur cluster, and the mech-
anism of the bifurcated electron transfer from ubiquinol to the
high and low potential chains of the bc1 complex.
( 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
The cytochrome (cyt.) bc1 complex (ubiquinol:cyt. c oxido-
reductase, E.C.1.10.2.2) is the middle section of the respira-
tory chain of mitochondria and many bacteria. It oxidizes
ubiquinol and reduces a small soluble cyt. c. Part of the free
energy released is coupled to development of a transmem-
brane gradient in the electrochemical potential of the hydro-
gen ion, which serves as the energy source for a number of
other processes including adenosine triphosphate (ATP) syn-
thesis. The mitochondrial complex is a homodimer of mono-
mers consisting of 10 or 11 di¡erent subunits. At the time of
the previous Nobel symposium on membrane proteins, a
three-dimensional model at around 20 A= was available from
electron microscopy/image reconstruction [1]. Over the past
decade X-ray crystallographic structures of the bc1 complex
have become available at successively higher resolution and
completeness [2^10] so we now have a fairly detailed under-
standing of the structure of the mitochondrial enzyme. In
collaboration with Fevzi Daldal we are currently determining
the structure of the cyt. bc1 complex from Rhodobacter cap-
sulatus. The overall structures of the mitochondrial and bac-
terial enzymes are shown in Fig. 1.
Although protein architecture is certainly interesting for its
own sake, the major impetus for the structural studies of the
respiratory complexes has been to further our understanding
of how these enzymes work. In contrast to the situation with
cytochrome oxidase, a widely accepted mechanism to account
for the detailed stoichiometry of charge and proton translo-
cation by the bc1 complex was available before the ¢rst crystal
structure emerged. Therefore the role of the structural studies
in elucidating the function has not been to provide hints of
possible mechanisms but rather to con¢rm (or refute) predic-
tions of this model (Mitchell’s protonmotive Q-cycle mecha-
nism [11,12]) and to elucidate in detail how the protein meets
the postulates required by the mechanism.
The crystallographic structures have for the most part con-
¢rmed the predictions made by the Q-cycle mechanism, and
have not turned up any details inconsistent with that mecha-
nism. Disappointingly none of the structures has revealed
quinone in any form at the QO site (quinol oxidation site
proposed by protonmotive Q-cycle hypothesis), and this is
certainly a goal to strive for, however the failure so far can
readily be explained by the facts that the best structures are
from preparations with low quinone content and/or are ob-
tained in the presence of tight-binding QO site inhibitors that
displace quinone. So for modeling the QO site reaction we
have to rely on models of quinoid inhibitors bound at the
site and on comparisons with quinone binding sites in other
structures. Quinone analogs whose binding at the QO site has
been described from high-resolution structures include stigma-
tellin, HHDBT [13], HQNO [10], and famoxadone [9]. For
comparison structures of the B. viridis reaction center are
available [14] with quinone (entry 2PRC) or stigmatellin
(4PRC) at the QB site.
2. A new crystal form of the vertebrate cyt. bc1 complex
Our latest additions to this series of structures are obtained
from a new crystal form of the bovine enzyme in the ortho-
rhombic space group P212121 (cell edges about 130U175U
230) with a dimer in the asymmetric unit. The crystals di¡ract
to beyond 2.0 A= , but at present the high mosaicity limits
accurate data to around 2.1 A= . We have recently deposited
structures 1PP9 (with stigmatellin at the QO site) and 1PPJ
(with stigmatellin and antimycin bound). A manuscript de-
scribing the details of these structures and comparing with
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previous structures is being prepared. Here we present only
the binding of stigmatellin at the QO site (Fig. 2) as a model
for ubiquinone binding.
3. Binding mode of ubiquinone and quinoid inhibitors at the
QO site
Shortly after evidence began to mount that the iron^sulfur
cluster had nitrogenous as well as sulfur ligands [15,16], it was
proposed by Rich and Robertson et al. [18] that one of the
ligands for quinone/quinol at the QO site was a histidine serv-
ing also as ligand for the Fe2S2 cluster. These proposals were
based partly on analogy with the QA and QB sites of bacterial
photosynthetic reaction centers, but also on the changes in
electron paramagnetic resonance (EPR) spectra and midpoint
potential of the iron^sulfur protein (ISP) depending on the
occupant of QO, which will be discussed below and were
seen as evidence of a close interaction between the cluster
and the occupant of the QO site.
The presence of a strong hydrogen bond between the QO
site occupant and a histidine ligand of the ISP center was
con¢rmed at least in the case of stigmatellin in 1998 when
Zhang et al. [4] reported this hydrogen bond in the crystal
structure of the stigmatellin-loaded avian bc1 complex. It has
since been observed in the fungal [7] and bovine (this work)
complexes with stigmatellin, in the fungal complex with an-
other inhibitor HHDBT [13], and recently in a bovine com-
plex with NQNO [10].
In this paper we argue that this strong H-bond between the
ISP cluster ligand histidine and substrate or inhibitor bound
in a pocket of cyt. b is central to the explanation of a body of
inter-related phenomena concerning the e¡ects of redox state,
QO site inhibitors, and site-directed mutations in the ISP
‘neck’ region on the resting position, midpoint potential,
and EPR lineshape of the ISP. And we propose that the redox
properties of the complex between the ISP and quinone at the
QO site could be su⁄cient to ensure the bifurcated electron
transfer at the QO site.
Fig. 2A shows the headgroup of stigmatellin and surround-
ing residues of the binding pocket from our structure 1PPJ.
Previous structures of the chicken (2bcc) and fungal (1ezv,
1kb9) complexes have the same binding mode. The headgroup
is suspended by strong H-bonds on either side of the ring. One
connects the phenolic OH to Glu271 of cyt. b. The other
connects the carbonyl oxygen to NO2 of His161 in the ISP.
The two stigmatellin methoxy oxygens are within H-bonding
distance of the same residues (His161 and Glu272) but with
relatively long bond lengths (3.4^3.5 A= vs. 2.6^2.7 A= for the
strong bonds mentioned above). The phenolic OH is further
bonded through a water molecule to the other carboxylate
oxygen of Glu271. Otherwise the binding appears to be Van
der Waals and hydrophobic, involving in particular Leu121,
Met129, Phe274, and Tyr278. The close contact of the related
inhibitor HHDBT with Tyr279 (corresponding to Tyr278 in
the beef sequence) has been proposed [13] to represent a weak,
edge-on aromatic H-bond, and the same argument could be
made here.
The interaction with His161 is similar to the interaction
between stigmatellin at the QB site and His L190 in the
B. viridis reaction center (PDB entry 4PRC) except that in
that case the histidine NN1 atom binds stigmatellin and NO2
binds the iron atom, while in the bc1 structure the histidine
Fig. 1. Overall structure of the cyt. bc1 complex. On the left is the vertebrate complex, a homodimer of hetero-11-mers. On the right is the
complex of R. capsulatus, a dimer of heterotrimers containing only the three redox center-carrying subunits cyt. b, cyt. c1, and the Rieske ISP.
The vertebrate complex is a composite of PDB entries 1QRC, 1BBC, and 1BE3. The complex of R. capsulatus is from a structure currently
being re¢ned in the authors’ lab.
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ring N’s have their roles reversed. H-bond distances from the
ring N to stigmatellin carbonyl and methoxy oxygens are 2.72
and 3.06 A= in 4PRC, versus 2.64 and 3.48 A= in 1PPJ.
It is generally assumed that quinone in at least some of its
redox states and some part of the catalytic cycle, binds in the
manner of stigmatellin, H-bonded between His161 of the ISP
and E271 of cyt. b. Fig. 2B shows ubiquinone modeled into
the density of stigmatellin, on the assumption that stigmatellin
Fig. 2. Binding of stigmatellin, and proposed binding mode of ubiquinone, in the QO site. A shows the binding of stigmatellin in structure
1PPJ. The electron density map is a 2Fo-Fc map phased using the structure with stigmatellin omitted, to show the shape of the electron density
due to the inhibitor. B shows the result of ¢tting a model for ubiquinone into that density and carrying out positional re¢nement against the
data of 1PPJ, to obtain a model for the binding of ubiquinone in the QO site. Protein residues in cyt. b are labeled with the one-letter amino
acid code followed by residue number, those in the ISP are preceded by ‘R:’.
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binds as a ubiquinone analog and hence must present a sim-
ilar shape to the binding pocket. The ¢t is quite good for the
headgroup, with ¢ve of the six ring substituents ¢tting into
lobes of density from the corresponding substituents of stig-
matellin. The isoprenoid tail does not ¢t well, however there is
a lot of room here and the tail in the ubiquinone model makes
no clashes.
The relative orientation of ubiquinone and stigmatellin de-
picted here is the same as in the QB site of the reaction center
based on entries 4PRC and 2PRC, that is with the carbonyl
O4 atom of ubiquinone (2,3 dimethoxy 5 methyl 6-polyiso-
prenyl 1,4-benzoquinone) and the carbonyl O4 of stigmatellin
oriented toward the His ligand.
4. EPR lineshape of the ISP Fe2S2 cluster: primarily an
indicator for the presence or absence of an H-bond between
cluster ligand His161 of the ISP and the occupant of the
QO site?
A number of early EPR studies summarized [19] indicated
an interaction of the ISP Fe2S2 cluster with oxidized quinone
or QO site inhibitors resulting in altered ISP lineshape. In later
years these results were extended to di¡erent inhibitors [20],
quinone-depleted membranes [21], isolated soluble form of the
ISP [22], and mutated complexes [23]. The EPR spectrum of
the isolated extrinsic, functional domain (ectodomain) of the
ISP shows a broad gx band at g=1.76. A similar spectrum is
obtained in the entire complex at low potentials where qui-
none is reduced or when quinone is absent due to extraction,
genetic manipulation, or the presence of inhibitors such as
myxothiazol which displace quinone and do not themselves
interact with the ISP.
In the presence of oxidized quinone all the g-values are
shifted, the gx being most characteristic. The gx band sharpens
and shifts to 1.80 when there is quinone in the QO site. Several
QO site inhibitors have similar e¡ects. Stigmatellin for exam-
ple results in a greatly sharpened gx peak shifted to 1.79. It
seems safe to see the sharpened gx band at V1.79 as an
indication that the ISP ectodomain is H-bonded to the occu-
pant of the QO site. From what we know of the structure of
the QO site this implies that the ectodomain is in the B posi-
tion (see below). The precise g-value and bandwidth is an
indication of what that occupant is. More re¢ned analysis
may tell something about the environment of the QO site,
such as the presence of a second quinone [21], but the most
obvious and major factor a¡ecting the lineshape is the pres-
ence or absence of this H-bond between the ISP and the QO
site occupant.
5. Movement of the ectodomain of the ISP in the catalytic
cycle
One ¢nding that came out of the structures, and that was
neither required nor expected from the Q-cycle model, was the
fact that the ectodomain of the ISP was found in at least two
di¡erent positions, one with the Fe2S2 cluster near the pre-
sumed QO quinone binding site and one near cyt. c1 [4]. Since
neither of the positions was close enough to both of these
redox partners to allow electron transfer at the observed rates
from a single site, it was inferred that electron transfer be-
tween these centers depended upon mobility of the ISP as part
of the reaction cycle. The position in proximity to the QO sites
is referred to as the proximal or ‘B’ position, and the position
close to cyt. c1 as the distal or ‘C’ position.
This raised a number of questions not directly related to the
Q-cycle mechanism, but rather to the motion of the ISP. Is the
motion between the two sites driven by the conformational
changes in the rest of the complex, or is it passive di¡usion
between the sites (Fig. 3)? If it is driven, do conformational
changes exert force directly on the ectodomain to move it
between positions, or do conformational changes adjust the
a⁄nity of one or both binding sites so that by passive di¡u-
sion most of the ISP ends up in one condition? What exper-
imental factors a¡ect the position of the ectodomain in the
resting enzyme? What techniques can we use to ascertain the
resting position if not in a crystalline state?
In the crystals the ectodomain position is a¡ected by the
presence and species of QO site inhibitors [4,5]. This was ex-
plained based on random di¡usion between binding sites of
di¡erent a⁄nity, with the a⁄nity of the B position determined
largely by the availability and strength of the H-bond between
the QO site occupant and His161 [24]. This still seems to be
the best explanation of most of the crystal data on movement.
Orientation-dependent EPR spectroscopy of oriented ¢lms
of protein was used to demonstrate changes in position as a
function of redox state of the Fe2S2 center and another com-
ponent presumed to be quinone at the QO site [25]. In order to
apply this technique to the oxidized cluster, which is not para-
magnetic, the sample was reduced by Q-irradiation after ¢xing
the position by drying and freezing. We interpret the redox
dependence by supposing that a strong H-bond is formed
between the reduced ISP and oxidized quinone, but not be-
tween the two species when both are reduced or both are
oxidized. This is supported by the e¡ect of redox state on
the EPR lineshape of the cluster, discussed above.
6. Redox midpoint potential of the ISP cluster
The midpoint potential of the ISP is a¡ected by QO site
inhibitors. Most dramatically, stigmatellin raises it by V250
mV [20]. This was attributed to stigmatellin binding to the
reduced ISP some 17 000 times more tightly than to the oxi-
dized. Other inhibitors raise the midpoint potential by lesser
amounts [26], while DBMIB lowers it [27], implying tighter
binding to the oxidized form.
All of this was understood before the structures were deter-
mined or movement of the ectodomain was suspected. A re-
cent paper from Crofts and coworkers [28] extends the model
to include equilibria between di¡erent positions of the ecto-
domain and competition with endogenous quinone. MOA in-
hibitors [29] such as myxothiazol lower the midpoint slightly
but leave the lineshape similar to that of the isolated ectodo-
main. It seems likely that their e¡ect is due to displacement of
quinone, which apparently, like stigmatellin, binds to the re-
duced ISP more tightly albeit by a smaller margin.
Since the inhibitor can only bind to ISP in the B position,
anything that a¡ects the equilibrium between the B and C
positions may also a¡ect the midpoint potential. This may
explain the e¡ect of genetically engineered insertions and de-
letions in the ‘neck region’ of the ISP on activity and midpoint
potential of the ISP cluster. Insertion of a few residues results
in an inactive complex. From the EPR lineshape, the ISP
resides mainly in the B position bound to quinone. As dis-
cussed in [30], one explanation involves the fact that rotation
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of the ectodomain to the B position results in stretching the
neck region and partially uncoiling a helix in this region. It
may be that this helix serves as a ‘spring’ to keep some tension
pulling the ectodomain out of the B position, promoting dis-
sociation of the product complex. Lengthening the neck re-
gion weakens the tension and the complex dwells with the ISP
in position B too long to be kinetically competent.
7. Enforced bifurcation of electron transfer to the high and low
potential chains upon oxidation of quinol at the QO site
This so-called ‘bifurcated reaction’ is required by the
Q-cycle mechanism to account for the observed proton and
charge translocation stoichiometry, which results in conserva-
tion of a large part of the free energy available in the reaction.
One electron passes via the ISP and cyt. c1 to cyt. c (the ‘high
potential chain’), providing the driving force for the reaction.
The other electron is recycled via the cyt. b to reduce quinone
back to quinol.
This halves the number of low potential electrons consumed
per turnover, and due to the fact that quinone reduction site is
in protonic equilibrium with the N side of the membrane,
provides the proton uptake mechanism of the proton pump.
If both electrons took the thermodynamically favorable path
down the high potential chain, the bc1 complex would be half
a Mitchellian protonmotive loop and could pump no protons
by itself. And if the electrons were free to go independently
and reversibly by both pathways, it would enable futile cycles
that would drain o¡ the proton gradient produced by the
other complexes.
To the extent that we accept the model for quinone binding
presented in Fig. 2B, the X-ray structures set the stage in
Fig. 3. Cartoon depicting two paradigms for motion of the ISP ectodomain within the catalytic cycle. The ISP is colored by temperature factor,
green in the transmembrane helix and better-ordered parts of the ectodomain, fading into yellow and red in the more distal parts of the ecto-
domain. The Fe2S2 cluster is represented by space-¢lling spheres. Cyt. b is magenta, with blue stigmatellin indicating the QO site. The heme of
cyt. c1 is the red ball-and-stick model behind the cluster. The left-hand cartoon depicts the ectodomain as a loosely tethered balloon, bu¡etted
by Brownian motion as it di¡uses between binding sites of di¡erent a⁄nity. The right-hand model depicts the ISP as part of an orchestrated
machine, with its ectodomain motions conformationally linked to events elsewhere in the complex.
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which the bifurcated reaction must take place. Although the
binding pocket for quinone is in cyt. b, one of its strongest
ligands is His161 of the ISP. His161 directly ligates the Fe2S2
cluster of the ISP, and thus is a part of the Z-orbital system
through which the unpaired electron of the reduced ISP is
delocalized (Fig. 4).
Thus the Z-orbital systems of the two reacting centers ubi-
quinone and the Fe2S2 cluster are separated by a single strong
hydrogen bond, with atom-to-atom distance of 2.8 A= in the
model of Fig. 2. While the non-adiabatic tunneling mecha-
nism is not applicable at such short distances, application of
the ‘Dutton Ruler’, eq. 3 of [31], with vG=3V to get an
order-of-magnitude estimate leads to predicted electron trans-
fer rates of greater than 1013 s31, i.e. fast on the EPR time
scale (109 s31) and extremely fast compared to the maximal
observed rate for the QO site reaction [32]. Thus on the time
scale we are interested in, it might be more realistic to con-
sider the electron is delocalized over both centers.
The actual mechanism might involve a bond rearrangement
tautomerism as suggested by Rich [33] for the transfer of H‡
through histidine. A possible scheme of bond rearrangements
is indicated in Fig. 4. If the complex is a resonance hybrid of
two or more tautomers, this would allow partial transfer of
the electron between the two centers depending on the relative
stability of the tautomers.
Note that it is assumed that quinol is the H-bond donor
and His161 the acceptor, in contrast to previous models
[17,18,33,34]. This does not imply the need for deprotonation
of either quinol or the ISP before binding, rather the initial
complex may have quinol accepting followed by dissociation
of the proton not involved in the H-bond. In any case the
result is a strong, short H-bond between groups both having
pKas above neutrality. The transition state may involve a sym-
metrical H-bond of the type described [35,36].
Robertson et al. [18] suggested that the strong orbital over-
lap between quinone, ISP cluster, and cyt. b in their model of
quinone binding would be important for the kind of concerted
mechanism proposed by Meinhardt and Crofts [37] for the
quinol oxidation reaction. The present paper can be seen as
an extension of that idea in light of the evidence that the ISP
is, but heme b is not, involved in ligating quinone.
The reaction complex, or enzyme^substrate complex, is
formed by binding of oxidized ISP to ubiquinol at the QO
site. Note that this is di¡erent from (having one less electron
than) the complex between reduced ISP and quinol which we
supposed not to form in order to explain the ISP position and
lineshape at low redox potential. Unfortunately little is known
about it. It is presumably transient except under conditions
where cyt. b is fully reduced and the high potential chain
oxidized (as in the ‘oxidant-induced reduction’ experiments).
Neither the reduced quinol nor the oxidized Fe2S2 cluster are
paramagnetic, and even if one electron resides on the ISP in
the reaction complex, spin coupling between the semiquinone
and ISP electrons would abolish the EPR spectrum.
On the other hand a good deal is known about the product
complex between oxidized quinone and the reduced ISP,
which is paramagnetic and has been studied extensively by
EPR spectroscopy. As summarized above, a large body of
data on the e¡ects of inhibitors and redox state on the line-
shape and redox midpoint potential of the ISP can be ex-
Fig. 4. Reactant and product complexes at the QO site. The reactant complex is formed from reduced ubiquinol and oxidized ISP, however the
distribution of the electrons over the two centers in the ground state is unknown. The product complex is formally made by removing one elec-
tron from the quinol and transferring the other to the ISP cluster. It is suggested that H-bond between the two reactants constitutes an insig-
ni¢cant barrier to electron transfer, so that the electron is e¡ectively delocalized between the two centers and no unstable semiquinone-like spe-
cies occurs during oxidation of the reactant complex by cyt. b.
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plained at least qualitatively based on the existence or not of
an H-bond between the QO site occupant and the reduced
ISP. We would thus say that the sharpened gx = 1.80 lineshape
is the signature of the product complex. Furthermore it seems
reasonable to view the crystal structure with stigmatellin’s
carbonyl oxygen H-bonded to the reduced ISP as an analog
of the product complex.
The enzyme^substrate or reaction complex, formed by re-
duced quinone and oxidized ISP, is formally a reduced form
of this product complex. To emphasize this fact we can call
the H-bonded complex of the ISP with quinone or quinol the
‘R-complex’. I will refer to the product complex as the oxi-
dized or one-electron form of the R-complex, and the reaction
complex as the reduced or two-electron R-complex. The fully
reduced, three-electron complex between reduced ISP and qui-
nol does not form, which is the reason for the disappearance
of the gx = 1.8 signal and the movement of the ISP ectodo-
main at low redox potential.
One way of describing the proposed mechanism is to say
that the ¢rst electron from quinol is transferred to cyt. b, not
the ISP (but see below). The distance from the QO site to
heme bL is 10 A= edge to edge, consistent with the turnover
rate and measured rate constants provided the vG is not too
unfavorable and the reductant species is present at high occu-
pancy. Such models have been rejected in the past because of
the extreme instability of the semiquinone species at the QO
site, which would make ubiquinol a poor one-electron reduc-
tant and the vG for the reaction highly unfavorable. We pro-
pose that even though quinol may be a poor one-electron
reductant, the reduced R-complex (consisting of quinol com-
plexed to the oxidized ISP) is a good one-electron reductant,
because the product is not unstable semiquinone but rather
the oxidized R-complex, a stable complex that can be ob-
served by EPR to form at high occupancy from reduced
ISP and oxidized ubiquinone or quinone analog inhibitors.
However it is not quite right to say that the ¢rst electron
goes to cyt. b, because the electron is transferred to cyt. b
from the reduced R-complex, and we don’t know where the
electrons are in that. We suggested above that electrons could
be delocalized on the reaction time scale between the Fe2S2
center and the quinoid system via the H-bond. If in fact one
electron from the substrate quinol resides mainly on the Fe2S2
center in the reduced R-complex, then we have the spin-
coupled complex of semiquinone and reduced ISP described
by Link [34]. If there is very little electron transfer from qui-
nol to ISP in the reduced R-complex, but the cloud of the
second electron sloshes over to the Fe2S2 center concomi-
tantly with the transfer of the ¢rst electron to cyt. b, then
we have a concerted mechanism as proposed by Meinhardt
and Crofts [37] and by Snyder et al. [38].
Once the oxidized R-complex is formed and relaxes to its
ground state, it is pretty clear from the EPR spectrum that the
unpaired electron is on the ISP cluster. However it is tempting
to speculate that the sharpening and shifting to higher g-val-
ues is indicative of mixing in some radical g=2.0 signal due to
a minor occupancy on the semiquinone. Slightly di¡erent
spectral e¡ects of quinone and di¡erent inhibitors on the
ISP spectrum would be due to the di¡erent environment of
the electron on the di¡erent quinoid systems, as well as di¡er-
ent distribution between quinone and Fe2S2 cluster.
It is a truism that the reaction complex is the reduced form
of the product complex: it has the same composition with one
extra electron. And thermodynamically it is a good one-elec-
tron reductant, due to the stability of the product complex.
However it will not be a good reductant kinetically if its ox-
idation proceeds by way of an unstable semiquinone species.
We hypothesize that the reaction complex (reduced R-com-
plex) proceeds, upon removal of one electron at a relatively
low potential by cyt. b, directly to the oxidized R-complex
without passing through any unstable intermediates which
would result in kinetic barriers.
The justi¢cation for the hypothesis is that, with a few rea-
sonable assumptions about the properties of the R-complex, it
provides a mechanism for enforcing the bifurcated reaction.
Let us consider possible pathways to allow both electrons to
pass to the high potential chain, violating the bifurcation.
Once the complex has formed, before the electron transfer
to cyt. b, what could go wrong? Suppose the complex disso-
ciates, where do the electrons go? They cannot both go on the
ISP center, as it is a one-electron carrier. If one electron goes
with the ISP leaving the other electron on the semiquinone to
react with oxygen or with the ISP on a second cycle, bifurca-
tion would be violated. However this would not happen if the
semiquinone is su⁄ciently unstable: The energy of breaking
the bond (separating the spin-coupled electrons, and forming
the unstable semiquinone) would make it occur at an insig-
ni¢cant rate. (This is the strong bond between reduced ISP
and stable semiquinone proposed by Link [34].) Essentially
the quinone is a two-electron carrier, and cannot leave the
site in the half-reduced form any more than the ISP can leave
in the doubly reduced form. So the only way for the reduced
R-complex to dissociate is back to the starting materials, with
nothing lost and nothing gained.
Once the ¢rst electron has transferred to cyt. b, it has to be
prevented from escaping back to the high potential chain.
There is always the possibility for transferring back to the
R-complex as long as it remains, however this just reverses
the previous electron transfer and returns to the reduced com-
plex. Once the oxidized R-complex dissociates into reduced
ISP and quinone, however, there is no possibility for the elec-
tron to return. Even with a favorable vG the 10 A= distance
reduces the rate to about what is required for the forward
reaction. With a highly unfavorable vG due to formation of
the unstable semiquinone, the rate would be negligible. So
once the R-complex has dissociated, the only way for the
electron from heme bL to come back to the QO site would
be after reformation of the oxidized R-complex from reduced
ISP and oxidized quinone, as happens in EPR titration experi-
ments and as presumably happens during reversed electron
transfer experiments. However this is just reversal of the nor-
mal reaction, and nothing is lost.
This model avoids one potential problem of all sequential
transfer mechanisms with the ¢rst electron going to the ISP.
This is a possible bypass of the antimycin block by a scheme
involving cycles of the normal Q-cycle reaction, in which one
electron is transferred to the ISP and the second to cyt. b,
alternating with perverted cycles in which one electron trans-
fers to the ISP and the resulting semiquinone is reduced by an
electron from cyt. b.
It must be acknowledged at this point that no new mecha-
nism has been proposed ^ this is a superset of the schemes of
Link [34] and Snyder et al. [38]. However we feel this way of
looking at the problem leads to a useful sharpening of the
distinctions between two classes of mechanisms: Those in
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which cyt. b is reduced by quinol complexed with the ISP as
described here, and those in which quinol reduces the ISP and
dissociates giving a short-lived semiquinone that serves as the
reductant for cyt. b. Consideration of the former mechanisms
should focus our attention on the electronic structure of the
reduced R-complex and the transition state(s) on the path to
the oxidized R-complex. It is expected that proximity of the
Z-orbital systems in the product complex will allow facile
transfer of one electron from quinol to the cluster before or
concertedly with transfer of the other electron to cyt. b, avoid-
ing any unstable semiquinone-like species.
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